open access

Vol 70, No 5 (2012)
Original articles
Published online: 2012-05-23
Submitted: 2012-12-28
Get Citation

Periprocedural and late complications after percutaneous closure of patent foramen ovale: a single centre experience

Przemysław Węglarz, Ewa Konarska−Kuszewska, Katarzyna Spisak−Borowska, Jerzy Machowski, Agnieszka Drzewiecka−Gerber, Piotr Kuszewski, Christopher L. Jackson, Grzegorz Opala, Maria Trusz−Gluza
Kardiol Pol 2012;70(5):478-485.

open access

Vol 70, No 5 (2012)
Original articles
Published online: 2012-05-23
Submitted: 2012-12-28

Abstract

Background: Patent foramen ovale (PFO) is a potential risk factor for ischaemic stroke in young individuals. An interventional method of secondary stroke prevention in PFO patients is its percutaneous closure.
Aim: To assess safety and effectiveness (i.e. lack of residual shunt) of percutaneous PFO closure in patients with history of cryptogenic cerebrovascular event.
Methods:
149 patients (56 men/93 women), aged 39 ± 12 years, underwent percutaneous PFO closure. The implantation was performed under local anaesthesia, guided by trans-oesophageal echocardiography (TEE) and fluoroscopy. Follow-up trans-thoracic echocardiography (TTE) was performed at 1 month and follow-up TEE at 6-months. In cases of residual shunt, additional TEE was performed after ensuing 6 months.
Results:
Effective PFO closure (no residual shunt) was achieved in 91.3% patients at 6 months and 95.3% patients at 12 months. In 2 patients transient atrial fibrillation was observed during the procedure. In 2 patients, a puncture site haematoma developed and in 1 patient superficial thrombophlebitis was noted. In 1 patient a small pericardial effusion was observed, which resolved at day 3 post-procedurally, after administration of non-steroidal anti-inflammatory drugs.
Conclusions: Percutaneous PFO closure seems to be a safe procedure when performed in a centre with adequate expertise with regard to these procedures.

Abstract

Background: Patent foramen ovale (PFO) is a potential risk factor for ischaemic stroke in young individuals. An interventional method of secondary stroke prevention in PFO patients is its percutaneous closure.
Aim: To assess safety and effectiveness (i.e. lack of residual shunt) of percutaneous PFO closure in patients with history of cryptogenic cerebrovascular event.
Methods:
149 patients (56 men/93 women), aged 39 ± 12 years, underwent percutaneous PFO closure. The implantation was performed under local anaesthesia, guided by trans-oesophageal echocardiography (TEE) and fluoroscopy. Follow-up trans-thoracic echocardiography (TTE) was performed at 1 month and follow-up TEE at 6-months. In cases of residual shunt, additional TEE was performed after ensuing 6 months.
Results:
Effective PFO closure (no residual shunt) was achieved in 91.3% patients at 6 months and 95.3% patients at 12 months. In 2 patients transient atrial fibrillation was observed during the procedure. In 2 patients, a puncture site haematoma developed and in 1 patient superficial thrombophlebitis was noted. In 1 patient a small pericardial effusion was observed, which resolved at day 3 post-procedurally, after administration of non-steroidal anti-inflammatory drugs.
Conclusions: Percutaneous PFO closure seems to be a safe procedure when performed in a centre with adequate expertise with regard to these procedures.
Get Citation

Keywords

patent foramen ovale; PFO; complications; closure procedures

About this article
Title

Periprocedural and late complications after percutaneous closure of patent foramen ovale: a single centre experience

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 70, No 5 (2012)

Pages

478-485

Published online

2012-05-23

Bibliographic record

Kardiol Pol 2012;70(5):478-485.

Keywords

patent foramen ovale
PFO
complications
closure procedures

Authors

Przemysław Węglarz
Ewa Konarska−Kuszewska
Katarzyna Spisak−Borowska
Jerzy Machowski
Agnieszka Drzewiecka−Gerber
Piotr Kuszewski
Christopher L. Jackson
Grzegorz Opala
Maria Trusz−Gluza

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl